BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23230458)

  • 1. Expansion of recruitment time window in antihypertensive treatment of acute cerebral hemorrhage (ATACH) II trial.
    Qureshi A; Palesch Y;
    J Vasc Interv Neurol; 2012 Aug; 5(supp):6-9. PubMed ID: 23230458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale.
    Qureshi AI; Palesch YY
    Neurocrit Care; 2011 Dec; 15(3):559-76. PubMed ID: 21626077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial.
    Qureshi AI; Foster LD; Lobanova I; Huang W; Suarez JI
    Cerebrovasc Dis; 2020; 49(3):244-252. PubMed ID: 32585668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II at Japan site: study design and advance construction of domestic research network].
    Sato S; Yamamoto H; Qureshi AI; Palesch YY; Toyoda K;
    Rinsho Shinkeigaku; 2012; 52(9):642-50. PubMed ID: 22989898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes: A Secondary Analysis of the ATACH-2 Randomized Clinical Trial.
    Shoamanesh A; Morotti A; Romero JM; Oliveira-Filho J; Schlunk F; Jessel MJ; Ayres AM; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Martin RH; Qureshi AI; Greenberg SM; Rosand J; Goldstein JN;
    JAMA Neurol; 2018 Jul; 75(7):850-859. PubMed ID: 29710119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Acute Hypertensive Response in Intracerebral Hemorrhage Patients After ATACH-2 Trial.
    Majidi S; Suarez JI; Qureshi AI
    Neurocrit Care; 2017 Oct; 27(2):249-258. PubMed ID: 28004328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.
    Morotti A; Brouwers HB; Romero JM; Jessel MJ; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Greenberg SM; Martin RH; Qureshi AI; Rosand J; Goldstein JN;
    JAMA Neurol; 2017 Aug; 74(8):950-960. PubMed ID: 28628707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study.
    Qureshi AI; Palesch YY; Martin R; Novitzke J; Cruz-Flores S; Ehtisham A; Ezzeddine MA; Goldstein JN; Hussein HM; Suri MF; Tariq N;
    Arch Neurol; 2010 May; 67(5):570-6. PubMed ID: 20457956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH): rationale and design.
    Qureshi AI
    Neurocrit Care; 2007; 6(1):56-66. PubMed ID: 17356194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Run-up to participation in ATACH II in Japan.
    Toyoda K; Sato S; Koga M; Yamamoto H; Nakagawara J; Furui E; Shiokawa Y; Hasegawa Y; Okuda S; Sakai N; Kimura K; Okada Y; Yoshimura S; Hoshino H; Uesaka Y; Nakashima T; Itoh Y; Ueda T; Nishi T; Gotoh J; Nagatsuka K; Arihiro S; Yamaguchi T; Minematsu K
    J Vasc Interv Neurol; 2012 Aug; 5(supp):1-5. PubMed ID: 23230457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late Neurological Deterioration after Acute Intracerebral Hemorrhage: A post hoc Analysis of the ATACH-2 Trial.
    Okazaki S; Yamamoto H; Foster LD; Fukuda-Doi M; Koga M; Ihara M; Toyoda K; Palesch YY; Qureshi AI
    Cerebrovasc Dis; 2020; 49(1):26-31. PubMed ID: 32045911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Achievement of Blood Pressure Lowering and Hematoma Growth in Acute Intracerebral Hemorrhage: Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement-Intracerebral Hemorrhage Study.
    Yamaguchi Y; Koga M; Sato S; Yamagami H; Todo K; Okuda S; Okada Y; Kimura K; Shiokawa Y; Kamiyama K; Itabashi R; Hasegawa Y; Kario K; Fujita K; Kumamoto M; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yoshimura S; Nagatsuka K; Toyoda K;
    Cerebrovasc Dis; 2018; 46(3-4):118-124. PubMed ID: 30199854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.
    Qureshi AI; Palesch YY; Barsan WG; Hanley DF; Hsu CY; Martin RL; Moy CS; Silbergleit R; Steiner T; Suarez JI; Toyoda K; Wang Y; Yamamoto H; Yoon BW;
    N Engl J Med; 2016 Sep; 375(11):1033-43. PubMed ID: 27276234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study).
    Koga M; Toyoda K; Yamagami H; Okuda S; Okada Y; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Hasegawa Y; Kario K; Osaki M; Miyagi T; Endo K; Nagatsuka K; Minematsu K;
    J Hypertens; 2012 Dec; 30(12):2357-64. PubMed ID: 22990355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate and Predictors of Unanticipated Surgical Evacuation in Patients with Intracerebral Hemorrhage: Post Hoc Analysis of ATACH 2 Trial.
    Qureshi AI; Lobanova I; Huang W; Saeed O; Suarez JI
    World Neurosurg; 2020 Sep; 141():e935-e940. PubMed ID: 32561489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage.
    Qureshi AI; Palesch YY; Martin R; Novitzke J; Cruz-Flores S; Ehtisham A; Ezzeddine MA; Goldstein JN; Kirmani JF; Hussein HM; Suri MF; Tariq N; Liu Y;
    Neurocrit Care; 2011 Dec; 15(3):428-35. PubMed ID: 21573860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling blood pressure soon after intracerebral hemorrhage: The SAMURAI-ICH Study and its successors.
    Toyoda K; Koga M;
    Hypertens Res; 2022 Apr; 45(4):583-590. PubMed ID: 35260801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematoma Expansion Shift Analysis to Assess Acute Intracerebral Hemorrhage Treatments.
    Yogendrakumar V; Ramsay T; Menon BK; Qureshi AI; Saver JL; Dowlatshahi D
    Neurology; 2021 Aug; 97(8):e755-e764. PubMed ID: 34144995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical therapy for intracranial hemorrhage: update blood pressure management for prevention and acute treatment].
    Koga M; Toyoda K
    Rinsho Shinkeigaku; 2012; 52(11):1110-2. PubMed ID: 23196532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines.
    Qureshi AI; Harris-Lane P; Kirmani JF; Ahmed S; Jacob M; Zada Y; Divani AA
    Crit Care Med; 2006 Jul; 34(7):1975-80. PubMed ID: 16641615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.